drugset / Trial / NCT03106623
Study of ONO-8577 in Patients With Overactive Bladder
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The objective of the study is to evaluate the efficacy and safety of ONO-8577 compared to combination of solifenacin succinate and mirabegron or placebo for overactive bladder
Timeline
- Start
- 2017-04-07
- Primary completion
- 2017-08-29
- Completion
- 2017-09-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Mirabegron | Other / unclassified | — | Oral |
| Subject | ONO-8577 | Unknown | — | Oral |
| Comparator | Solifenacin | Small molecule | — | Oral |